anidulafungin has been researched along with selegiline in 2 studies
Studies (anidulafungin) | Trials (anidulafungin) | Recent Studies (post-2010) (anidulafungin) | Studies (selegiline) | Trials (selegiline) | Recent Studies (post-2010) (selegiline) |
---|---|---|---|---|---|
568 | 33 | 331 | 2,575 | 319 | 394 |
Protein | Taxonomy | anidulafungin (IC50) | selegiline (IC50) |
---|---|---|---|
Cholinesterase | Homo sapiens (human) | 0.0055 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0039 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.798 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.376 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.2127 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.9046 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.4408 | |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0067 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.1001 | |
Type-1 angiotensin II receptor | Sus scrofa (pig) | 0.048 | |
Alpha-synuclein | Homo sapiens (human) | 0.27 | |
Amine oxidase [flavin-containing] B | Bos taurus (cattle) | 1 | |
Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for anidulafungin and selegiline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for anidulafungin and selegiline
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |